FDA advisory panel narrowly recommends Merck's Covid pill for emergency use
Merck | Home
Japan seeking supply of Merck's oral COVID-19 drug this year | The Asahi Shimbun: Breaking News, Japan News and Analysis
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
Canada enters deals to procure Merck and Pfizer's Covid-19 antiviral pills
Merck Seeks FDA Authorization for First COVID-19 Pill | Everyday Health
Merck in Deal With Sinopharm to Bring Covid Antiviral Molnupiravir to China - Bloomberg
Merck's new COVID drug molnupiravir gets FDA consideration : Shots - Health News : NPR
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study - WSJ
With UK nod, Merck drug becomes world's 1st pill for Covid treatment - The Economic Times
Molnupiravir: long-term safety questions linger as approvals approach - Pharmaceutical Technology
Merck's Covid Pill Might Pose Risks for Pregnant Women - The New York Times
Merck KGaA's arpraziquantel validated by European Medicines Agency - PharmaTimes
Molnupiravir: Merck's Covid-19 antiviral less effective in new analysis - Pharmaceutical Technology
Pfizer COVID pill approved in Japan, following Merck treatment - Nikkei Asia
Explainer: How does Merck's COVID-19 pill compare to Pfizer's? | Reuters
Legavrio COVID-19 Pill by Merck Continues Its Slump | Fierce Pharma
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck's Molnupiravir: Second COVID Pill Is Second-Line, But Timing Helps Both Sponsor And US FDA :: Pink Sheet
Merck: Experimental Pill Treats COVID-19 at Earliest Stages | St Vincents Medical Center
Merck and Ridgeback begin Phase III trial of molnupiravir for Covid-19
Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat COVID-19
Merck's COVID pill loses its lustre: what that means for the pandemic
Merck signs $1.2 billion deal with US government for experimental COVID treatment - ABC News
